Medical imaging executives and radiologists are still concerned about receiving reimbursement from Medicare for diagnostic and interventional imaging.
Reimbursement continues to be a growing concern as imaging directors and managers noted they have very low confidence that they will receive adequate reimbursement from Medicare for imaging.
The latest Medical Imaging Confidence Index (MICI) data showed that medical imaging managers are even more discouraged about reimbursement than this time last year, when the confidence score was 64. The confidence score for the second quarter of 2014 was 58. The index evaluated the outlooks of 158 hospital imaging directors and managers.
It's not all bad though. Managers are very confident that internal operating and staff costs will remain constant and their departments will maintain or grow as a profit center. The consensus on monthly growth in diagnostic and interventional radiology is neutral, similar to this time last year. But managers did show concern about having access to capital for imaging equipment and IT needs, a concern that they did not have one year ago.
Here are the full results for the second quarter of 2014:
What do you think?
Medical Imaging Confidence Index (MICI) was co-developed by AHRA: The Association for Medical Imaging Management and The MarkeTech Group, owner of the imagePRO panel, launched in 2008. MICI data rely on the feedback of a statistical cohort of respondents from the imagePRO panel that accurately represent the US market hospital market by bedsize and geographic areas.
For more on the MICI, check out the FAQ here.
[[{"type":"media","view_mode":"media_crop","fid":"13646","attributes":{"alt":"","class":"media-image media-image-left","id":"media_crop_7553947536926","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"526","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: left;","title":" ","typeof":"foaf:Image"}}]]
[[{"type":"media","view_mode":"media_crop","fid":"13647","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_588727243724","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"527","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"float: right;","title":" ","typeof":"foaf:Image"}}]]
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.